Australian Clinical Labs (ASX:ACL) Cash Receipts from Operating Activities : A$687.1 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Cash Receipts from Operating Activities?

Australian Clinical Labs's Cash Receipts from Operating Activities for the six months ended in Dec. 2023 was A$346.0 Mil.

Australian Clinical Labs's Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 was A$687.1 Mil.

Australian Clinical Labs Cash Receipts from Operating Activities Historical Data

The historical data trend for Australian Clinical Labs's Cash Receipts from Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Cash Receipts from Operating Activities Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Cash Receipts from Operating Activities

661.97

990.24

718.73

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash Receipts from Operating Activities	Get a 7-Day Free Trial			491.83	498.41	377.72	341.01	346.05

Australian Clinical Labs Cash Receipts from Operating Activities Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

GuruFocus lists following items in "Cash Receipts from Operating Activities" section for non-financial companies:
Receipts from Customers
Receipts from Government Grants
Other Cash Receipts from Operating Activities

Cash Receipts from Operating Activities for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$687.1 Mil.

Australian Clinical Labs Cash Receipts from Operating Activities Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Cash Receipts from Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Cash Receipts from Operating Activities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines